A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.
The large study was conducted by Fl�vio A. Cadegiani, MD, MSc, PhD. Cadegiani is a board-certified endocrinologist with a master's degree and doctorate degree in clinical endocrinology.
No comments:
Post a Comment